Literature DB >> 24988166

[Epstein-Barr virus infection with severe consequences. EBV, haemophagocytic lymphohistiocytosis and Hodgkin lymphoma with Down syndrome].

Pieter C J Kuitert1, Floor C H Abbink, Chantal J M Broers, Paul van der Valk, A Marceline van Furth, Martijn van der Kuip.   

Abstract

BACKGROUND: Over 90% of the population is infected with the Epstein-Barr virus (EBV). Following primary infection, the virus remains latent in B-lymphocytes. In isolated cases, especially in immunocompromised patients, the Epstein-Barr virus can result in a chronic active infection (CAEBV). CASE DESCRIPTION: We describe an 11-year-old boy with Down syndrome who was admitted because of fever of unknown origin during several periods. Serological findings (high VCA-IgG and absent EBNA-IgG) were suggestive of CAEBV, which was confirmed by the high circulating EBV viral load. During admission the clinical picture worsened and our patient developed pancytopenia, which led us to diagnose concurrent haemophagocytic lymphohistiocytosis and Hodgkin lymphoma.
CONCLUSION: CAEBV is the result of deficiency in cellular immunity, which in this patient could possibly be attributed to deficiencies in the immune system associated with Down syndrome. CAEBV is difficult to treat, and it can come with life-threatening complications such as haemophagocytic lymphohistiocytosis.

Entities:  

Mesh:

Year:  2014        PMID: 24988166

Source DB:  PubMed          Journal:  Ned Tijdschr Geneeskd        ISSN: 0028-2162


  2 in total

1.  Killer-specific secretory (Ksp37) gene expression in subjects with Down's syndrome.

Authors:  Michele Salemi; Concetta Barone; Maria Concetta Morale; Salvatore Caniglia; Carmelo Romano; Maria Grazia Salluzzo; Rosanna G Galati Rando; Alda Ragalmuto; Paolo Bosco; Corrado Romano
Journal:  Neurol Sci       Date:  2016-03-31       Impact factor: 3.307

2.  Hemophagocytic lymphohistiocytosis presented with fever of unknown origin: A case study and literature review.

Authors:  Atousa Hakamifard; Masoud Mardani; Tahereh Gholipur-Shahraki
Journal:  Clin Case Rep       Date:  2021-03-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.